4//SEC Filing
Lenington Rachel 4
Accession 0001209191-21-063207
CIK 0001620463other
Filed
Nov 4, 8:00 PM ET
Accepted
Nov 5, 5:02 PM ET
Size
5.5 KB
Accession
0001209191-21-063207
Insider Transaction Report
Form 4
Lenington Rachel
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-03+150,000→ 150,000 totalExercise: $15.34Exp: 2031-11-02→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]One-fourth of the shares subject to the option vest on June 14, 2022 and one-fourth of the shares subject to the option vest on each subsequent anniversary thereafter.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001861194
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 8:00 PM ET
- Accepted
- Nov 5, 5:02 PM ET
- Size
- 5.5 KB